{
    "code": "10000746",
    "time": "2015-08-21 03:48:56",
    "許可證字號": "衛署菌疫輸字第000746號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/12\/11",
    "發證日期": "91\/12\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000074602",
    "中文品名": "\"百特\" 威保50U\/ml抗抑制子凝血複合物",
    "英文品名": "“BAXTER” FEIBA 50U\/ml",
    "適應症": "治療帶有抑制子之A型血友病患者的出血。\r\n治療帶有抑制子之B型血友病患者的出血。\r\n治療有後天性第八因子抗體之非血友病患者的出血。\r\n預防曾有嚴重出血或具高度重大出血風險之帶有抑制子A型血友病患者的出血。",
    "劑型": "243凍晶注射劑",
    "包裝": "1000U 20ML, 附20小瓶附溶液及輸注器",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0617501100  百特醫療產品股份有限公司",
    "申請商地址": "台北市敦化南路二段２１６號１５樓",
    "主製造廠": {
        "製造廠名稱": "F030018000  BAXTER AG",
        "製造廠廠址": "A-1220 VIENNA, INDUSTRIESTRASSES 67, AUSTRIA.",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRIA",
        "製程": ""
    },
    "CCC號列": "30021040002 抗血友病製劑Antihemophilia preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000720",
            "成分名稱": "HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY",
            "含量描述": "(40-1200)",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020007460001-104-04-28.pdf 020007460003-103-10-30.pdf 020007460002-103-10-30.pdf 020007460001-103-10-30.pdf 100007460005.jpg 100007460004.jpg 100007460003.jpg 100007460002.jpg 100007460001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000746&Seq=009&Type=9"
        },
        {
            "title": "外盒 020007460004-104-04-28.pdf 020007460003-104-04-28.pdf 100007460004.jpg 100007460003.jpg 100007460002.jpg 100007460001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000746&Seq=006&Type=8"
        }
    ]
}